Powder: -20°C for 3 years | In solvent: -80°C for 1 year
NMDAR/TRPM4-IN-2 是一种有效的 NMDAR/TRPM4 相互作用界面抑制剂。NMDAR/TRPM4-IN-2 保护小鼠免受 MCAO 诱导的脑损伤和 NMDA 诱导的视网膜神经节细胞丢失。NMDAR/TRPM4-IN-2 具有神经保护活性, 可预防 NMDA 诱导的海马神经元细胞死亡和线粒体功能障碍,其 IC50 值为 2.1 μM。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 185 | 现货 | ||
5 mg | ¥ 398 | 现货 | ||
10 mg | ¥ 617 | 现货 | ||
25 mg | ¥ 893 | 现货 | ||
50 mg | ¥ 1,180 | 现货 | ||
100 mg | ¥ 1,770 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 462 | 现货 |
产品描述 | NMDAR/TRPM4-IN-2 is a potent interfacial inhibitor of NMDAR/TRPM4 interaction.NMDAR/TRPM4-IN-2 protects against MCAO-induced brain damage and NMDA-induced retinal ganglion cell loss in mice.NMDAR/TRPM4-IN-2 has neuroprotective activity against NMDA-induced hippocampal neuronal cell death and mitochondrial dysfunction. NMDAR/TRPM4-IN-2 showed neuroprotective activity against NMDA-induced cell death and mitochondrial dysfunction in hippocampal neurons with an IC50 value of 2.1 μM. |
体外活性 |
NMDAR/TRPM4-IN-2 eliminates the CREB shutoff pathway and restores ERK1/2 activation and IEG induction while sparing the synaptic activity-driven, transcription-promoting activities of NMDARs.[1] NMDAR/TRPM4-IN-2 (compound 8) (0-10 μM) reduces the interactions of GluN2A and GluN2B with TRPM4 in a dose-dependent manner.[1] |
分子量 | 330.092 |
分子式 | C11H19BrCl2N2 |
CAS No. | 2243506-33-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 112.5 mg/mL (340.8 mM), Sonication is recommended.
H2O: 90.0 mg/mL (272.7 mM), Sonication is recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO / H2O | 1 mM | 3.0295 mL | 15.1473 mL | 30.2946 mL | 75.7365 mL |
5 mM | 0.6059 mL | 3.0295 mL | 6.0589 mL | 15.1473 mL | |
10 mM | 0.3029 mL | 1.5147 mL | 3.0295 mL | 7.5736 mL | |
20 mM | 0.1515 mL | 0.7574 mL | 1.5147 mL | 3.7868 mL | |
50 mM | 0.0606 mL | 0.3029 mL | 0.6059 mL | 1.5147 mL | |
100 mM | 0.0303 mL | 0.1515 mL | 0.3029 mL | 0.7574 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
NMDAR/TRPM4-IN-2 2243506-33-2 MAPK Membrane transporter/Ion channel Neuroscience ERK TRP/TRPV Channel NMDAR iGluR Inhibitor inhibitor inhibit